Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Ozempic The SUSTAIN-6 trials showed that semaglutide may reduce cardiovascular events like heart attack and stroke in high-risk patients with T2D
For this reason, those experienced in obesity management increasingly refer to obesity medications like Ozempic as lifelong medications, similar to maintenance medications people take for heart disease, diabetes, and other chronic conditions
Ozempic is available as a single-use injection pen in 0.25mg, 0.5mg, and 1mg strengths
To date, there are 4 DPP-4 inhibitors approved by FDA, including sitagliptin (2006), saxagliptin (2009), linagliptin (2011), and alogliptin (2013)
Route of Administration 16.2.7
People can access the treatment without the diabetic diagnosis and lose that weight they are tired of lugging around
